VE

Very Good Tour Co.,Ltd.

A South Korean travel company offering global tour packages, flights, hotels, and corporate travel.

094850 | KO

Overview

Corporate Details

ISIN(s):
KR7094850005
LEI:
Country:
South Korea
Address:
서울특별시 중구 서소문로 135 (서소문동, 연호빌딩), 중구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Very Good Tour Co., Ltd. (참좋은여행) is a South Korea-based travel company specializing in domestic and international tour packages. The company plans, develops, and sells a diverse range of travel products, including guided tours to destinations across Asia, Europe, and North America. Its services also encompass airline ticket sales, hotel and condominium reservations, charter flight operations, and corporate overseas travel planning. A subsidiary of Samchunly Co., Ltd., the company operates a real-time online booking system and a mobile application to serve its customers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 762.4 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 521.5 KB
2025-04-30 00:00
Regulatory News Service
소속부변경
Korean 3.6 KB
2025-03-21 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 24.5 KB
2025-03-21 00:00
Board/Management Information
대표이사변경
Korean 10.4 KB
2025-03-13 00:00
Audit Report / Information
감사보고서제출
Korean 18.9 KB
2025-03-13 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 442.6 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 79.9 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 75.9 KB
2025-03-06 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 78.6 KB
2025-02-20 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 13.3 KB
2025-02-20 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 5.2 KB
2025-02-06 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.1 KB
2024-12-13 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2024-12-13 00:00
Notice of Dividend Amount
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Korean 6.4 KB

Automate Your Workflow. Get a real-time feed of all Very Good Tour Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Very Good Tour Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Very Good Tour Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advancing high-grade copper and precious metal projects from discovery to production.
Canada
COR
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden
CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland
CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America
CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America
CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America
CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan
6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America
CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan
4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.